- Category
- Micro (2022-23)
- Udyam number
- UDYAM-JH-20-0027223

Biocherry Pharmaceuticals Private Limited
About Biocherry Pharmaceuticals Private Limited
Data last updated:
Biocherry Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 04 May 2022.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51909JH2022PTC018602.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar Singh and Vikash Kumar.
Its last annual general meeting (AGM) was held on 30 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Shankar Sahu Jhiri Gram Ratu Ravi Steel Chowk Kamre, Ranchi, Jharkhand, India – 835222.
As per the financials filed for FY 2023, the company reported a revenue of ₹92,366. For the same year it recorded a net profit of ₹1,982 (net margin 2.1%) and EBITDA of ₹2,082 (EBITDA margin 2.3%).
Biocherry Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0027223). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Biocherry Pharmaceuticals
Contact details
Biocherry Pharmaceuticals Private Limited's registered office is in Ranchi, Jharkhand.
- Registered AddressC/O Shankar Sahu Jhiri Gram Ratu Ravi Steel Chowk Kamre, Ranchi, Jharkhand, India – 835222
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biocherry Pharmaceuticals Private Limited
FY 2023 filings availableBiocherry Pharmaceuticals Private Limited reported revenue of ₹92,366 for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹2,082 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹1,982 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | 2.3% |
| Net Profit Margin | 2.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Biocherry Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biocherry Pharmaceuticals Private Limited
Biocherry Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Singh | Director | 04 May 2022 | 4 Years 6 Months | Current |
| Vikash Kumar Also directs: Jayshubha Construction Private Limited | Director | 04 May 2022 | 4 Years 6 Months | Current |
Peer comparison
Biocherry Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hazor Pharmaceuticals Private Limited | ₹93,979 (FY 2025) | -94.0% | Allahabad, Uttar Pradesh, India | |||
| Loriox India Pharmaceuticals Private Limited | ₹93,884 (FY 2024) | Hyderabad, Telangana, India | ||||
| Edenton Pharmaceuticals Private Limited | ₹93,388 (FY 2025) | Vasai, Maharashtra, India | ||||
| Banny Pharmaceuticals Private Limited | ₹93,240 (FY 2021) | Hyderabad, Telangana, India | ||||
| Sanlagan Pharmaceuticals Private Limited | ₹92,852 (FY 2025) | Pune, Maharashtra, India | ||||
| Biocherry Pharmaceuticals Private Limitedthis company | ₹92,366 (FY 2023) | ₹1,982 | 2.1% | Ranchi, Jharkhand, India | ||
| Ementis Pharmaceuticals Private Limited | ₹92,006 (FY 2023) | Pune, Maharashtra, India | ||||
| Herabdayal Pharmaceuticals Private Limited | ₹92,000 (FY 2024) | Delhi, India | ||||
| Vanheilen Pharmaceuticals India Private Limited | ₹90,350 (FY 2018) | Kollam, Kerala, India | ||||
| Goodwin Medicine(India) Pharmaceuticals Private Limited | ₹90,327 (FY 2024) | 902.0% | Bilaspur, Chhattisgarh, India | |||
| Numberdar Pharmaceuticals Private Limited | ₹89,999 (FY 2024) | -1.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Biocherry Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biocherry Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocherry Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biocherry Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biocherry Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rakesh Kumar Singh was appointed as Director on 04 May 2022.
Frequently asked questions
Biocherry Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. The company works in specialty, within the trading industry. It was incorporated on 04 May 2022 (4+ years old) and is registered under CIN U51909JH2022PTC018602.
Biocherry Pharmaceuticals has 2 current directors:
- Rakesh Kumar Singh - Director
- Vikash Kumar - Director
The latest financial statements of Biocherry Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 December 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Biocherry Pharmaceuticals is U51909JH2022PTC018602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biocherry Pharmaceuticals was incorporated on 04 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Biocherry Pharmaceuticals by revenue are Hazor Pharmaceuticals Private Limited, Loriox India Pharmaceuticals Private Limited, Edenton Pharmaceuticals Private Limited, Banny Pharmaceuticals Private Limited, Sanlagan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rakesh Kumar Singh was appointed as Director on 04 May 2022. Vikash Kumar was appointed as Director on 04 May 2022.
Yes, Biocherry Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0027223).
The registered office of Biocherry Pharmaceuticals is at CO Shankar Sahu Jhiri Gram Ratu Ravi Steel Chowk Kamre, Ranchi, Jharkhand, India – 835222.
Biocherry Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Biocherry Pharmaceuticals is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.

